Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Accumulated Expenses of $129.4 million in Q1 2026, up 428.79% quarter-over-quarter from $24.5 million in Q4 2025, and up 935.33% on a YoY basis from $12.5 million in Q1 2025.
Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $129.4 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 935.33% year-over-year to $129.4 million; the TTM figure through Mar 2026 stood at $129.4 million (up 935.33% YoY), while the FY2025 annual figure was $139.0 million, up 56.58% from the prior year.
- Accumulated Expenses was $129.4 million for Q1 2026 at Phibro Animal Health, up from $24.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $139.0 million in Q2 2025 to a low of $3.4 million in Q3 2023.
- Historically, Accumulated Expenses has averaged $63.4 million across 5 years, with a median of $72.0 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses tumbled 94.99% in 2023, then soared 2307.5% in 2024.
- A 5-year view of Accumulated Expenses shows it stood at $5.4 million in 2022, then soared by 1300.56% to $75.3 million in 2023, then surged by 56.16% to $117.6 million in 2024, then slumped by 79.18% to $24.5 million in 2025, then surged by 428.79% to $129.4 million in 2026.
- The last three Accumulated Expenses figures came in at $129.4 million (Q1 2026), $24.5 million (Q4 2025), and $121.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 129.40 Mn |
| Dec 31, 2025 | 24.47 Mn |
| Sep 30, 2025 | 121.10 Mn |
| Jun 30, 2025 | 139.02 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 117.56 Mn |
| Sep 30, 2024 | 82.87 Mn |
| Jun 30, 2024 | 88.79 Mn |
| Mar 31, 2024 | 30.91 Mn |
| Dec 31, 2023 | 75.28 Mn |
| Sep 30, 2023 | 3.44 Mn |
| Jun 30, 2023 | 29.36 Mn |
| Mar 31, 2023 | 5.18 Mn |
| Dec 31, 2022 | 5.38 Mn |
| Sep 30, 2022 | 68.70 Mn |
| Jun 30, 2022 | 80.24 Mn |
| Dec 31, 2021 | 6.01 Mn |
| Sep 30, 2021 | 26.55 Mn |
| Jun 30, 2021 | 86.38 Mn |
| Mar 31, 2021 | 30.82 Mn |